Other · developed by Sunshine Lake Pharma Co.
HEC169584 is an agent studied in non-alcoholic steatohepatitis, a form of non-alcoholic fatty liver disease.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07099118 | Phase 1 | Non - Alcoholic Steatohepatitis | Recruiting | SBFM |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Non - Alcoholic Steatohepatitis
Updated Nov 1, 2026. Something wrong or missing? Report it on the SBFM page.
See SBFM's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
SBFM catalysts and pipeline →